期刊文献+

MRI三维评价乳腺癌新辅助化疗后残余肿瘤范围的准确性 被引量:22

Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in breast cancer with three-dimensional reconstruction technique
原文传递
导出
摘要 目的 基于三维测量技术分析MRI评价乳腺癌新辅助化疗(NAC)后残余肿瘤的准确性和临床价值.方法 选取2010年7月至2013年8月山东省肿瘤医院乳腺病中心接受6~8周期NAC的61例乳腺浸润性导管癌患者为研究对象进行前瞻性研究.患者年龄31 ~ 70岁,中位年龄49岁.NAC后行MRI检查.NAC后手术标本制作次连续病理大切片,显微镜下勾画残余肿瘤范围,Photoshop软件配准,3D-DOCTOR软件三维重建病理及MRI残余肿瘤,三维测量病理和MRI残余肿瘤的最大径、最大截面积和体积,分别采用Spearman秩相关检验和Bland-Altman法评价两者测量残余肿瘤范围的相关性和一致性.结果 病理和MRI对残余肿瘤的最大径、最大截面积和体积的测量结果呈正相关(r分别为0.942、0.941、0.903,均P=0.00),在残余肿瘤的最大径、最大截面积方面,病理与MRI的相关性优于超声二维测量(Z=6.48、6.18,均P=0.00).MRI对最大径和最大截面积的测量较病理略有低估,而对体积的测量较病理略有高估,两者一致性较好(最大径平均差值0.3 cm,95% CI:-1.43 ~1.90 cm;最大截面积平均差值1.39 cm2,95% CI:-9.55~12.34 cm2;体积平均差值-0.433 cm3,95%CI:-7.065~6.199 cm3).结论 NAC后MRI三维重建图像能准确评价残余肿瘤的立体空间范围,有助于选择NAC后降期保乳患者. Objective To evaluate the accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy (NAC) with three-dimensional (3D) reconstruction technique.Methods This was a prospective study.The data of 61 patients with pathologically proven solitary invasive ductal carcinoma (Ⅱ A-ⅢC) who had received 6 to 8 cycles of NAC from July 2010 to August 2013 was analyzed.All the patients were female,aging from 31 to 70 years with a median of 49 years.Breast specimen after surgery was prepared with part-mount sub-serial section,and residual tumors were microscopically outlined,scanned and registered by Photoshop software.The 3D model of pathological and MRI residual tumors was reconstructed with 3D-DOCTOR software.The longest diameter,maximum cross-section area and volume of the residual tumors determined using 3D MRI were compared with 3D pathological findings,and the associations between MRI and pathology were analyzed by Spearman rank correlation and Bland-Altman analysis.Results The longest diameter,maximum cross-section area and volume of the residual tumors after NAC measured by MRI and pathology was highly correlated (r =0.942,0.941,0.903,all P =0.00).MRI appears to underestimate pathology in the longest diameter,maximum cross-section area,but slightly overestimate in volume,and two methods had a good consistence (MD =0.3 cm,95% CI:-1.43 to 1.9 cm; MD =1.39 cm2,95% CI:-9.55 to 12.34 cm2 ; MD =-0.433 cm3,95% CI:-7.065 to 6.199 cm3).Conclusion 3D MRI reconstruction after NAC could accurately detects the residual tumors after neoadjuvant chemotherapy,and contribute to select patients who received breast conserving therapy after NAC with tumor downstaging.
出处 《中华外科杂志》 CAS CSCD 北大核心 2015年第4期280-284,共5页 Chinese Journal of Surgery
基金 山东省科技发展计划资助项目,山东省医药卫生科技发展计划资助项目
关键词 乳腺肿瘤 抗肿瘤联合化疗方案 磁共振成像 成像 三维 显微切片术 Breast neoplasms Antineoplastic combined chemotherapy protocols Magnetic resonance imaging Imaging,three-dimensional Microtomy
  • 相关文献

参考文献14

  • 1KaufmannM,von MinckwitzG,BearHD,et al.Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer:new perspectives 2006[J].Ann Oncol,2007,18(12):1927-1934.
  • 2KaufmannM,von MinckwitzG,MamounasEP,et al.Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer[J].Ann Surg Oncol,2012,19(5):1508-1516.
  • 3KaufmannM,HortobagyiGN,GoldhirschA,et al.Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer:an update[J].J Clin Oncol,2006,24(12):1940-1949.
  • 4GentiliniO,IntraM,GandiniS,et al.Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy.The role of surgical margins on outcome[J].J Surg Oncol,2006,94(5):375-379.
  • 5YehE,SlanetzP,KopansDB,et al.Prospective comparison of mammography,sonography,and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer[J].AJR Am J Roentgenol,2005,184(3):868-877.
  • 6LonderoV,BazzocchiM,Del FrateC,et al.Locally advanced breast cancer:comparison of mammography,sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy[J].Eur Radiol,2004,14(8):1371-1379.
  • 7PartridgeSC,GibbsJE,LuY,et al.MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival[J].AJR Am J Roentgenol,2005,184(6):1774-1781.
  • 8NakaharaH,YasudaY,MachidaE,et al.MR and US imaging for breast cancer patients who underwent conservation surgery after neoadjuvant chemotherapy:comparison of triple negative breast cancer and other intrinsic subtypes[J].Breast Cancer,2011,18(3):152-160.
  • 9BhattacharyyaM,RyanD,CarpenterR,et al.Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer[J].Br J Cancer,2008,98(2):289-293.
  • 10AkazawaK,TamakiY,TaguchiT,et al.Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy[J].Breast J,2006,12(2):130-137.

二级参考文献7

  • 1李金锋,欧阳涛,王天峰,解云涛,林本耀.局部进展期及较大乳腺癌的保乳治疗[J].中华外科杂志,2005,43(15):1008-1010. 被引量:17
  • 2Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst, 2000,92:205-216.
  • 3Sakamoto G, Inaji H, Akiyama F, et al. General rules for clinical and pathological recording of breast cancer 2005. Breast Cancer, 2005,12 Suppl : 1-27.
  • 4Wendy D, Constance L, Savannah P. Breast MRI for cancer detection and characterization:a review of evidence-based clinical applications. Acad Radiol, 2008, 15:408-416.
  • 5NCCN乳腺癌临床实践指南(中国版)专家组.NCCN乳腺癌临床实践指南(中国版)[EB/OL].[2008-10-09].www.nccnchina, orghttp://www, nccn-china, org/images/2008PDF/2008% 20Breast% 20Cancer% 20guideline% 20Chinese% 20edition. pdf.
  • 6Bollet MA, Thibauh F, Bouillon K, et al. Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase Ⅱ study. Int J Radiat Oncol Biol Phys,2007,69 : 13-18.
  • 7Cheung YC, Chen SC, Su MY, et al. Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin ) with serial enhanced MRI. Breast Cancer Res Treat,2003,78:51-58.

共引文献16

同被引文献252

  • 1姜大庆,赵林,龙飞,张斌.乳腺癌新辅助化疗中Ki-67、bcl-2及AI的表达与化疗效果关系的研究[J].中国实用外科杂志,2005,25(4):230-231. 被引量:14
  • 2刘玉林,陈宪.乳腺癌的动态增强MRI诊断[J].国外医学(临床放射学分册),2006,29(2):112-115. 被引量:16
  • 3顾雅佳,汪晓红,肖勤,杨文涛,曾炜,唐峰,毛健,郑晓静,彭卫军,冯晓源.乳腺导管原位癌及其微浸润的磁共振成像评价[J].中华放射学杂志,2007,41(3):248-253. 被引量:43
  • 4关晏星,雷秋模,熊秋云,曹亚丽,欧阳军,瞿伟,杨晓青,张青,张庆,江美英,楼捷,潘志敏.乳腺癌新辅助化疗后残留肿瘤^(99)Tc^m-MIBI摄取与预后因素的关系[J].中国医学影像技术,2007,23(6):921-924. 被引量:4
  • 5Hohenberger W, Weber K, Matzel K, et al. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome [J]. Colorectal Dis, 2009, 11 (4) :354-364.
  • 6Hogan AM, Winter DC. Complete mesocolic excision-a marker of surgical quality.9 [ J]. J Gastrointest Surg, 2009, 13 (10) : 1889- 1891.
  • 7West NP, Hohenberger W, Weber K, et al. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon [J]. J Clin Oncol, 2010, 28(2) : 272-278.
  • 8Chen SL, Bilehik AJ. More extensive nodal dissection improves survival for stages [ to I[ of colon cancer: a population-based study[J]. Ann Surg, 2006, 244(4) :602-610.
  • 9Kritsanasakul A, Boonpipattanapong T, Wanitsuwan W, et al. Impact of lymph node retrieval on surgical outcomes in colorectal cancers[J]. J Surg Oncol, 2012, 105(3) :238-242.
  • 10Johnson PM, Porter GA, Ricciardi R, et al. Increasing negative lymph node count is independently associated with improved long- term survival in stage Ill B and ~I C colon cancer [ J ]. J Clin Oncol, 2006, 24(22): 3570-3575.

引证文献22

二级引证文献162

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部